Prevalência de sarcopenia e fatores associados em pacientes em hemodiálise
Barra lateral de artigos
Publicado:
Dez 23, 2021
Palavras-chave:
hemodiálise, insuficiência renal crônica, sarcopenia
Conteúdo do artigo principal
Resumo
Objetivo: avaliar a prevalência de sarcopenia e os fatores associados em pacientes com doença renal crônica (DRC) em hemodiálise (HD). Métodos: Estudo transversal que avaliou pacientes portadores de DRC em HD no período de janeiro a outubro de 2016 em dois centros de diálise situados em Recife, Pernambuco. Para o diagnóstico de sarcopenia, foram considerados os critérios propostos pelo Consenso Europeu de Sarcopenia de 2019, que preconiza a baixa força muscular como critério principal. Foram avaliadas covariáveisdemográficas, clínicas, antropométricas e comportamentais. Resultados: Foram incluídos 108 pacientes, com média de idade de 51,4 ± 17,0 anos e distribuição homogênea entre os sexos. A sarcopenia foi presente em 38,9% da população, dos quais 69% apresentavamsarcopenia grave. Maior prevalência de sarcopenia foi observada entre os homens (60% vs. 17%; p < 0,001), nos que não tinham companheiros (48,1% vs. 30,4%; p < 0,045), em tabagistas (50% vs. 30%; p < 0,034), com baixo peso (baixo peso 73,3%, eutróficos 33,9%, excesso de peso 32,4%; p = 0,001) e naqueles com níveis de albumina normais (47,5% vs. 28,6%; p = 0,045). Conclusão: Aproximadamente um em cada três pacientes nefropatas em terapia hemodialítica apresentaram sarcopenia e dentre estes, a maioria tinha a forma grave dessa condição. A sarcopenia urêmica foi mais prevalente no sexo masculino, nos indivíduos sem companheiros, baixo peso, nos tabagistas e entre aqueles com níveis normais de albumina.
Detalhes do artigo
Como Citar
1.
Nunes CF, Carvalho TR de, Duarte R da S, Barboza YACO, Lemos MCC de, Pinho CPS. Prevalência de sarcopenia e fatores associados em pacientes em hemodiálise. HSJ [Internet]. 23º de dezembro de 2021 [citado 19º de maio de 2024];11(4):61-9. Disponível em: https://portalrcs.hcitajuba.org.br/index.php/rcsfmit_zero/article/view/1153
Seção
ARTIGO ORIGINAL
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Os autores mantêm os direitos autorais e concedem ao HSJ o direito de primeira publicação. A partir de 2024, as publicações serão licenciadas sob a Attribution 4.0 International 
, permitindo seu compartilhamento, reconhecendo a autoria e publicação inicial nesta revista.
Os autores estão autorizados a assumir contratos adicionais separadamente para distribuição não exclusiva da versão do trabalho publicada nesta revista (por exemplo, publicação em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
Os autores são incentivados a publicar e distribuir seu trabalho on-line (por exemplo, em repositórios institucionais ou em sua página pessoal) a qualquer momento após o processo editorial.
Além disso, o AUTOR fica informado e consente que o HSJ possa incorporar seu artigo em bases de dados e indexadores científicos existentes ou futuros, nas condições definidas por estes a cada momento, o que envolverá, pelo menos, a possibilidade de que os titulares de esses bancos de dados podem executar as seguintes ações no artigo.
Referências
1. Cruz-Jentoft AJ, Bahat G, Bauer J, Boirie Y, Bruyère O, Cederholm T, et al. Sarcopenia: revised European consensus on definition and diagnosis. Age Ageing. 2019;48(1):16-31. https://doi.org/10.1093/ageing/afy169 PMid:30312372 PMCid:PMC6322506
2. Fahal Ibrahim H. Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant. 2014;29(9):1655-65. https://doi.org/10.1093/ndt/gft070 PMid:23625972
3. Ren H, Gong D, Jia F, Xu B, Liu Z. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016; 38(3):364-71. https://doi.org/10.3109/0886022X.2015.1132173 PMid:26738817
4. Hotta C, Hiraki K, Wakamiya A, Otobe Y, Watanabe S, Izawa KP, et al. Relation of physical function and physical activity to sarcopenia in hemodialysis patients: A preliminary study. Int J Cardiol. 2015;191:198-200. https://doi.org/10.1016/j.ijcard.2015.05.005 PMid:25974194
5. Kim JC, Shapiro BB, Zhang M, Li Y, Porszasz J, Bross R, et al. Daily physical activity and physical function in adult maintenance hemodialysis patients. J Cachexia Sarcopenia Muscle. 2014;5(3):209-20. https://doi.org/10.1007/s13539-014-0131-4 PMid:24777474 PMCid:PMC4159490
6. Sharma D, Hawkins M, Abramowitz MK. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clim J Am Soc Nephrol. 2014;9(12):2079-88. https://doi.org/10.2215/CJN.02140214 PMid:25392147 PMCid:PMC4255396
7. Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33(1):64-8. https://doi.org/10.1016/j.clnu.2013.04.002 PMid:23631844
8. Lauretani F, Russo CS, Bandinelli S, Benedeta B, Cavazzini C, Iorio AD, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851-60. https://doi.org/10.1152/japplphysiol.00246.2003 PMid:14555665
9. Sergi G, Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living caucasian older adults. Clin Nutrition. 2015;34(4):667-73. https://doi.org/10.1016/j.clnu.2014.07.010 PMid:25103151
10. Kyle UG, Bosaeus I, Lorenzo ADD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr. 2004;23(5):1226-43. https://doi.org/10.1016/j.clnu.2004.06.004 PMid:15380917
11. Soares V, Avelar IS, Andrade SRS, Vieira MF, Silva MS. Composição corporal de pacientes renais crônicos em hemodiálise: antropometria e análise vetorial por bioimpedância. Rev Latino-Am Enfermagem. 2013;21(6):1240-7. https://doi.org/10.1590/0104-1169.3060.2360 PMid:24402340
12. Barbosa-Silva TG, Menezes ABP, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136-41. https://doi.org/10.1016/j.jamda.2016.08.004 PMid:27650212
13. Van Kan GA, Rolland Y, Andrieu S, Bauer J, Béauchet Ó, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an international academy on nutrition and aging (IANA) task force. J. Nutr Health Aging. 2009;13(10):881-9. https://doi.org/10.1007/s12603-009-0246-z PMid:19924348
14. Olinto MTA, Nácul LC, Dias-da-Costa JS, Gigante DP, Menezes AMB, Macedo S. Níveis de intervenção para obesidade abdominal: prevalência e fatores associados. Cad. Saúde Pública. 2006;22(6):1207-15. https://doi.org/10.1590/S0102-311X2006000600010 PMid:16751960
15. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. WHO: Geneva: 2011 [cited 2021 Nov 15]. Available from: https://bit.ly/3wTamGX
16. Brock F, Bettinelli LA, Dobner T, Stobbe JC, Pomatti G, Telles CT. Prevalence of hypoalbuminemia and nutritional issues in hospitalized elders. Rev Latino-Am Enfermagem. 2016;24:e2736. https://doi.org/10.1590/1518-8345.0260.2736 PMid:27508908 PMCid:PMC4990035
17. Blackburn G, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr. 1977;1(1): 11-22. https://doi.org/10.1177/014860717700100101 PMid:98649
18. World Health Organization. Obesity: preventing and managing the global epidemic. WHO technical report series; 894. Geneva: WHO; 1999 [cited 2021 Nov 15]. Available from: https://bit.ly/3FbYrHg
19. Lipschitz DA. Screening for nutritional status in the elderly. Primar Care. 1994;21(1):55-67. https://doi.org/10.1016/S0095-4543(21)00452-8 PMid:8197257.
20. Blackburn GL, Thornton PA. Nutritional assessment of the hospitalized patient. Med Clin North Am. 1979;63(5):1103-15. https://doi.org/10.1016/S0025-7125(16)31663-7
21. American College of Sports Medicine. Guidelines for exercise testing and prescription / American College of Sports Medicine. 4th ed. Philadelphia: Wolters Kluwer; 1991. 314 p.
22. Kidney disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013 [cited 2021 Nov 15];3(1): 1-150. Avaiable from: https://bit.ly/3nfGl0W
23. Bataille S, Serveaux M, Carreno E, Pedinielli N, Darmon P, Robert A., et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654-60. https://doi.org/10.1016/j.clnu.2016.10.016 PMid:27816311
24. Cotrina BWM, Agurto FSRB, Carbajal DFM. Sarcopenia y fragilidad en sujetos sometidos a hemodiálisis en un centro de diálisis en el Perú. Rev Nutr Clin Metab. 2019;2(1):57-64. https://doi.org/10.35454/rncm.v2n1.060
25. Kim JK, Kim SG, Oh JE, Lee YK, Noh JW, Kim HJ, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34(3):599-607. https://doi.org/10.3904/kjim.2017.083 PMid:29161801 PMCid:PMC6506738
26. Morishita Y, Kubo K, Miki A, Ishibashi K, Kusano E, Nagata D. Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients. Intern Urol Nephrol. 2014;46(3):633-9. https://doi.org/10.1007/s11255-014-0662-9 PMid:24526334
27. Giglio J, Kamimura MA, Iamarca F, Rodrigues J, Santin F, Avesani CM. Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Renal Nut. 2018;28(3):197-207. https://doi.org/10.1053/j.jrn.2017.12.003 PMid:29673501
28. Janssen I, Baumgartner RN, Ross R, Rosemberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159(4);413-21. https://doi.org/10.1093/aje/kwh058 PMid:14769646
29. Leite LEA, Resende TL, Nogueira GM, Cruz IBM, Schneider RH, Gottilieb MGV. Envelhecimento, estresse oxidativo e sarcopenia: uma abordagem sistêmica. Rev Bras Geriatr Gerontol. 2012;15(2):365-80. https://doi.org/10.1590/S1809-98232012000200018
30. Wang Zhebin, Pang Y, Liu J, Wang J, Xie Z, Huang T. Association of healthy lifestyle with cognitive function among Chinese older adults. Eur J Clin Nutr. 2021;75(2):325-34. https://doi.org/10.1038/s41430-020-00785-2 PMid:33116235
31. Robards J, Evandrou M, Falkingham J, Vlachatoni A. Marital status, health and mortality. Maturitas. 2012;73(4):295-9. https://doi.org/10.1016/j.maturitas.2012.08.007 PMid:23007006 PMCid:PMC3635122
32. Dorosty A, Arero G, Chamar M, Tavakoli S. Prevalence of sarcopenia and its association with socioeconomic status among the elderly in Tehran. Ethiop J Health Sci. 2016;26(4):389-96. https://doi.org/10.4314/ejhs.v26i4.11 PMid:27587937 PMCid:PMC4992779
33. Confortin SC, Ono LM, Barbosa AR, d'Orsi E. Sarcopenia e sua associação com mudanças nos fatores socioeconômicos, comportamentais e de saúde: o EpiFloripa Elderly Study. Cad Saúde Pública. 2018;34(12):e00164917. https://doi.org/10.1590/0102-311x00164917 PMid:30517315
34. Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr. 2004;80(2):496-503. https://doi.org/10.1093/ajcn/80.2.496 PMid:15277176
35. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003;25(3):226-31. https://doi.org/10.1016/S0749-3797(03)00197-1
36. Lee SW, Auyeung TW, Kwok T, Lau EMC, Leung PC, Woo J. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology. 2007;53(6):404-10. https://doi.org/10.1159/000107355 PMid:17700027
37. Rom O, Kaisari S, Aizenbud D, Reznick AZ. Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown. Ann NY Acad Sci. 2012;1259:47-53. https://doi.org/10.1111/j.1749-6632.2012.06532.x PMid:22758636
38. Kilaru S, Frangos SG, Chen AH, Gortler D, Dhadwal AK, Araim O, et al. Nicotine: a review of its role in atherosclerosis. J Am Coll Surg. 2001;193(5):538-46. https://doi.org/10.1016/S1072-7515(01)01059-6
39. Kok MO, Hoekstra T, Twisk JWR. The longitudinal relation between smoking and muscle strength in healthy adults. Eur Adic Res. 2012;18(2):70-5. https://doi.org/10.1159/000333600 PMid:22178906
40. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimburg O, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephr. 2014;9(10):1720-8. https://doi.org/10.2215/CJN.10261013 PMid:25074839 PMCid:PMC4186520
41. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995;48(2):510-6. https://doi.org/10.1038/ki.1995.321 PMid:7564120
2. Fahal Ibrahim H. Uraemic sarcopenia: aetiology and implications. Nephrol Dial Transplant. 2014;29(9):1655-65. https://doi.org/10.1093/ndt/gft070 PMid:23625972
3. Ren H, Gong D, Jia F, Xu B, Liu Z. Sarcopenia in patients undergoing maintenance hemodialysis: incidence rate, risk factors and its effect on survival risk. Ren Fail. 2016; 38(3):364-71. https://doi.org/10.3109/0886022X.2015.1132173 PMid:26738817
4. Hotta C, Hiraki K, Wakamiya A, Otobe Y, Watanabe S, Izawa KP, et al. Relation of physical function and physical activity to sarcopenia in hemodialysis patients: A preliminary study. Int J Cardiol. 2015;191:198-200. https://doi.org/10.1016/j.ijcard.2015.05.005 PMid:25974194
5. Kim JC, Shapiro BB, Zhang M, Li Y, Porszasz J, Bross R, et al. Daily physical activity and physical function in adult maintenance hemodialysis patients. J Cachexia Sarcopenia Muscle. 2014;5(3):209-20. https://doi.org/10.1007/s13539-014-0131-4 PMid:24777474 PMCid:PMC4159490
6. Sharma D, Hawkins M, Abramowitz MK. Association of sarcopenia with eGFR and misclassification of obesity in adults with CKD in the United States. Clim J Am Soc Nephrol. 2014;9(12):2079-88. https://doi.org/10.2215/CJN.02140214 PMid:25392147 PMCid:PMC4255396
7. Kim JK, Choi SR, Choi MJ, Kim SG, Lee YK, Noh JW, et al. Prevalence of and factors associated with sarcopenia in elderly patients with end-stage renal disease. Clin Nutr. 2014;33(1):64-8. https://doi.org/10.1016/j.clnu.2013.04.002 PMid:23631844
8. Lauretani F, Russo CS, Bandinelli S, Benedeta B, Cavazzini C, Iorio AD, et al. Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95(5):1851-60. https://doi.org/10.1152/japplphysiol.00246.2003 PMid:14555665
9. Sergi G, Rui M, Veronese N, Bolzetta F, Berton L, Carraro S, et al. Assessing appendicular skeletal muscle mass with bioelectrical impedance analysis in free-living caucasian older adults. Clin Nutrition. 2015;34(4):667-73. https://doi.org/10.1016/j.clnu.2014.07.010 PMid:25103151
10. Kyle UG, Bosaeus I, Lorenzo ADD, Deurenberg P, Elia M, Gómez JM, et al. Bioelectrical impedance analysis-part I: review of principles and methods. Clin Nutr. 2004;23(5):1226-43. https://doi.org/10.1016/j.clnu.2004.06.004 PMid:15380917
11. Soares V, Avelar IS, Andrade SRS, Vieira MF, Silva MS. Composição corporal de pacientes renais crônicos em hemodiálise: antropometria e análise vetorial por bioimpedância. Rev Latino-Am Enfermagem. 2013;21(6):1240-7. https://doi.org/10.1590/0104-1169.3060.2360 PMid:24402340
12. Barbosa-Silva TG, Menezes ABP, Bielemann RM, Malmstrom TK, Gonzalez MC. Enhancing SARC-F: improving sarcopenia screening in the clinical practice. J Am Med Dir Assoc. 2016;17(12):1136-41. https://doi.org/10.1016/j.jamda.2016.08.004 PMid:27650212
13. Van Kan GA, Rolland Y, Andrieu S, Bauer J, Béauchet Ó, Bonnefoy M, et al. Gait speed at usual pace as a predictor of adverse outcomes in community-dwelling older people an international academy on nutrition and aging (IANA) task force. J. Nutr Health Aging. 2009;13(10):881-9. https://doi.org/10.1007/s12603-009-0246-z PMid:19924348
14. Olinto MTA, Nácul LC, Dias-da-Costa JS, Gigante DP, Menezes AMB, Macedo S. Níveis de intervenção para obesidade abdominal: prevalência e fatores associados. Cad. Saúde Pública. 2006;22(6):1207-15. https://doi.org/10.1590/S0102-311X2006000600010 PMid:16751960
15. World Health Organization. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. WHO: Geneva: 2011 [cited 2021 Nov 15]. Available from: https://bit.ly/3wTamGX
16. Brock F, Bettinelli LA, Dobner T, Stobbe JC, Pomatti G, Telles CT. Prevalence of hypoalbuminemia and nutritional issues in hospitalized elders. Rev Latino-Am Enfermagem. 2016;24:e2736. https://doi.org/10.1590/1518-8345.0260.2736 PMid:27508908 PMCid:PMC4990035
17. Blackburn G, Bistrian BR, Maini BS, Schlamm HT, Smith MF. Nutritional and metabolic assessment of the hospitalized patient. J Parenter Enteral Nutr. 1977;1(1): 11-22. https://doi.org/10.1177/014860717700100101 PMid:98649
18. World Health Organization. Obesity: preventing and managing the global epidemic. WHO technical report series; 894. Geneva: WHO; 1999 [cited 2021 Nov 15]. Available from: https://bit.ly/3FbYrHg
19. Lipschitz DA. Screening for nutritional status in the elderly. Primar Care. 1994;21(1):55-67. https://doi.org/10.1016/S0095-4543(21)00452-8 PMid:8197257.
20. Blackburn GL, Thornton PA. Nutritional assessment of the hospitalized patient. Med Clin North Am. 1979;63(5):1103-15. https://doi.org/10.1016/S0025-7125(16)31663-7
21. American College of Sports Medicine. Guidelines for exercise testing and prescription / American College of Sports Medicine. 4th ed. Philadelphia: Wolters Kluwer; 1991. 314 p.
22. Kidney disease: Improving Global Outcomes (KDIGO) CKD work group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl. 2013 [cited 2021 Nov 15];3(1): 1-150. Avaiable from: https://bit.ly/3nfGl0W
23. Bataille S, Serveaux M, Carreno E, Pedinielli N, Darmon P, Robert A., et al. The diagnosis of sarcopenia is mainly driven by muscle mass in hemodialysis patients. Clin Nutr. 2017;36(6):1654-60. https://doi.org/10.1016/j.clnu.2016.10.016 PMid:27816311
24. Cotrina BWM, Agurto FSRB, Carbajal DFM. Sarcopenia y fragilidad en sujetos sometidos a hemodiálisis en un centro de diálisis en el Perú. Rev Nutr Clin Metab. 2019;2(1):57-64. https://doi.org/10.35454/rncm.v2n1.060
25. Kim JK, Kim SG, Oh JE, Lee YK, Noh JW, Kim HJ, et al. Impact of sarcopenia on long-term mortality and cardiovascular events in patients undergoing hemodialysis. Korean J Intern Med. 2019;34(3):599-607. https://doi.org/10.3904/kjim.2017.083 PMid:29161801 PMCid:PMC6506738
26. Morishita Y, Kubo K, Miki A, Ishibashi K, Kusano E, Nagata D. Positive association of vigorous and moderate physical activity volumes with skeletal muscle mass but not bone density or metabolism markers in hemodialysis patients. Intern Urol Nephrol. 2014;46(3):633-9. https://doi.org/10.1007/s11255-014-0662-9 PMid:24526334
27. Giglio J, Kamimura MA, Iamarca F, Rodrigues J, Santin F, Avesani CM. Association of sarcopenia with nutritional parameters, quality of life, hospitalization, and mortality rates of elderly patients on hemodialysis. J Renal Nut. 2018;28(3):197-207. https://doi.org/10.1053/j.jrn.2017.12.003 PMid:29673501
28. Janssen I, Baumgartner RN, Ross R, Rosemberg IH, Roubenoff R. Skeletal muscle cutpoints associated with elevated physical disability risk in older men and women. Am J Epidemiol. 2004;159(4);413-21. https://doi.org/10.1093/aje/kwh058 PMid:14769646
29. Leite LEA, Resende TL, Nogueira GM, Cruz IBM, Schneider RH, Gottilieb MGV. Envelhecimento, estresse oxidativo e sarcopenia: uma abordagem sistêmica. Rev Bras Geriatr Gerontol. 2012;15(2):365-80. https://doi.org/10.1590/S1809-98232012000200018
30. Wang Zhebin, Pang Y, Liu J, Wang J, Xie Z, Huang T. Association of healthy lifestyle with cognitive function among Chinese older adults. Eur J Clin Nutr. 2021;75(2):325-34. https://doi.org/10.1038/s41430-020-00785-2 PMid:33116235
31. Robards J, Evandrou M, Falkingham J, Vlachatoni A. Marital status, health and mortality. Maturitas. 2012;73(4):295-9. https://doi.org/10.1016/j.maturitas.2012.08.007 PMid:23007006 PMCid:PMC3635122
32. Dorosty A, Arero G, Chamar M, Tavakoli S. Prevalence of sarcopenia and its association with socioeconomic status among the elderly in Tehran. Ethiop J Health Sci. 2016;26(4):389-96. https://doi.org/10.4314/ejhs.v26i4.11 PMid:27587937 PMCid:PMC4992779
33. Confortin SC, Ono LM, Barbosa AR, d'Orsi E. Sarcopenia e sua associação com mudanças nos fatores socioeconômicos, comportamentais e de saúde: o EpiFloripa Elderly Study. Cad Saúde Pública. 2018;34(12):e00164917. https://doi.org/10.1590/0102-311x00164917 PMid:30517315
34. Szulc P, Duboeuf F, Marchand F, Delmas PD. Hormonal and lifestyle determinants of appendicular skeletal muscle mass in men: the MINOS study. Am J Clin Nutr. 2004;80(2):496-503. https://doi.org/10.1093/ajcn/80.2.496 PMid:15277176
35. Castillo EM, Goodman-Gruen D, Kritz-Silverstein D, Morton DJ, Wingard DL, Barrett-Connor E. Sarcopenia in elderly men and women: the Rancho Bernardo study. Am J Prev Med. 2003;25(3):226-31. https://doi.org/10.1016/S0749-3797(03)00197-1
36. Lee SW, Auyeung TW, Kwok T, Lau EMC, Leung PC, Woo J. Associated factors and health impact of sarcopenia in older Chinese men and women: a cross-sectional study. Gerontology. 2007;53(6):404-10. https://doi.org/10.1159/000107355 PMid:17700027
37. Rom O, Kaisari S, Aizenbud D, Reznick AZ. Sarcopenia and smoking: a possible cellular model of cigarette smoke effects on muscle protein breakdown. Ann NY Acad Sci. 2012;1259:47-53. https://doi.org/10.1111/j.1749-6632.2012.06532.x PMid:22758636
38. Kilaru S, Frangos SG, Chen AH, Gortler D, Dhadwal AK, Araim O, et al. Nicotine: a review of its role in atherosclerosis. J Am Coll Surg. 2001;193(5):538-46. https://doi.org/10.1016/S1072-7515(01)01059-6
39. Kok MO, Hoekstra T, Twisk JWR. The longitudinal relation between smoking and muscle strength in healthy adults. Eur Adic Res. 2012;18(2):70-5. https://doi.org/10.1159/000333600 PMid:22178906
40. Isoyama N, Qureshi AR, Avesani CM, Lindholm B, Bàràny P, Heimburg O, et al. Comparative associations of muscle mass and muscle strength with mortality in dialysis patients. Clin J Am Soc Nephr. 2014;9(10):1720-8. https://doi.org/10.2215/CJN.10261013 PMid:25074839 PMCid:PMC4186520
41. Kaysen GA, Rathore V, Shearer GC, Depner TA. Mechanisms of hypoalbuminemia in hemodialysis patients. Kidney Int. 1995;48(2):510-6. https://doi.org/10.1038/ki.1995.321 PMid:7564120